A recombinant human bone morphogenetic protein (rhBMP-2) with a compression-resistant matrix intended for posterolateral lumbar spinal fusion in patients with symptomatic, single-level degenerative disc disease.
If you have a Hayes login, click here to view the full report on the Knowledge Center.